<!DOCTYPE html><html><head><title>Pharyngitis.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Guideline Title
</h3>
<div class='FieldValue'>
<div class="content_title">Pharyngitis.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Bibliographic Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>University of Michigan Health System. Pharyngitis. Ann Arbor (MI): University of Michigan Health System; 2013 May. 10 p.  [10 references]</td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: University of Michigan Health System. Pharyngitis. Ann Arbor (MI): University of Michigan Health System; 2006 Oct. 10 p. [9 references]</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Recommendations
</h2>
<div class='field field_text'>
<h3>
Major Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong><em>Note from the University of Michigan Health System (UMHS) and the National Guideline Clearinghouse (NGC)</em></strong>: The following guidance was current as of May 2013. Because UMHS occasionally releases minor revisions to its guidance based on new information, users may wish to consult the <a href="http://www.med.umich.edu/1info/fhp/practiceguides/pharyngitis.html" title="UMHS Web site">original guideline document</a>for the most current version.</p>
<p><strong>Note from NGC</strong>: The following key points summarize the content of the guideline. Refer to the full text for detailed information on each of the screening procedures.</p>
<p>The strength of recommendation (I-III) and levels of evidence (A-D) are defined at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Key Points</span></strong></p>
<p><strong>General Principles</strong></p>
<ul style="list-style-type: disc;">
    <li>Viral pathogens cause most cases of pharyngitis: around 90% in adults and 70% in children <em>[C]</em>. </li>
    <li>The primary reason to identify and treat group A streptococcal (GAS) pharyngitis is to decrease the risk of acute rheumatic fever (ARF) <em>[IB]</em>. The endemic incidence of ARF is around 0.23-1.88/100,000. </li>
    <li>Early treatment of GAS can decrease the time a patient is symptomatic by 1-2 days from a typical 3-7 days <em>[IB]</em> and can decrease the period of contagiousness <em>[IB]</em>. </li>
</ul>
<p><strong>Diagnosis</strong></p>
<ul style="list-style-type: disc;">
    <li>Signs/symptoms of severe sore throat, fever, tender anterior cervical lymphadenopathy, red pharynx with tonsillar swelling +/- exudate, and no cough indicate a higher probability of GAS pharyngitis for both adults and children. Algorithms of epidemiologic and clinical factors improve diagnosis by identifying patients with an exceedingly low risk of GAS infection <em>[C]</em>. </li>
    <li>Laboratory confirmation:
    <ul style="list-style-type: disc;">
        <li>Neither culture nor rapid antigen screen differentiate individuals with GAS pharyngitis from GAS carriers with an intercurrent viral pharyngitis. </li>
        <li>Consider clinical and epidemiological findings (see Table 2 in the original guideline document) when deciding to perform a microbiological test <em>[IB]</em>. </li>
        <li>Patients with manifestations highly suggestive of a viral infection such as coryza, scleral conjunctival inflammation, hoarseness, cough, discrete ulcerative lesions, or diarrhea, are unlikely to have GAS infection and generally should NOT be tested for GAS infection <em>[IIB]</em>. </li>
    </ul>
    </li>
    <li>Throat culture is the presumed "gold standard" for diagnosis. Rapid streptococcal antigen tests identify GAS more rapidly, but have variable sensitivity <em>[B]</em>.
    <ul style="list-style-type: disc;">
        <li>Reserve rapid strep tests for patients with a reasonable probability of having GAS. </li>
        <li>Confirm negative screen results by culture in patients &lt;16 years old (and consider in parents/siblings of school age children) due to their higher risk of acute rheumatic fever <em>[IIC]</em>. </li>
        <li>If screening for GAS in very low risk patients is desired, culture alone is cost-effective <em>[IIC]</em>. </li>
    </ul>
    </li>
</ul>
<p><strong>Treatment</strong></p>
<ul style="list-style-type: disc;">
    <li>Penicillin V is the drug of choice in patients who can swallow pills. </li>
    <li>If using suspension, amoxicillin is better tolerated than penicillin V due to the salty/bitter taste. </li>
    <li>Amoxicillin as a single daily dose (1 gram/day) for 10 days is as effective as penicillin V or amoxicillin given multiple times per day for 10 days. </li>
    <li>A single dose of intramuscular penicillin G benzathine avoids the problem of adherence, but is painful. </li>
    <li>If allergic to penicillin, a 10-day course of a first generation cephalosporin is indicated if no history of a type I hypersensitivity to penicillin. Oral clindamycin is an acceptable alternative, if one is unable to use a first generation cephalosporin. </li>
    <li>A macrolide is also acceptable for patients allergic to penicillins (resistant rates range 5-8%). </li>
    <li>Children with a recurrence of GAS pharyngitis shortly after completing a course of an oral antimicrobial agent can be retreated with the same agent, given an alternative oral drug, or given an intramuscular injection of penicillin G benzathine (expert opinions differ). </li>
    <li>Antibiotics must be started within 9 days after onset of acute illness and continued for 10 days (5 days for azithromycin) to eradicate GAS from the upper respiratory tract and prevent ARF <em>[D]</em>. </li>
</ul>
<p><strong>Controversial Areas</strong></p>
<ul style="list-style-type: disc;">
    <li>Diagnosis over the telephone based on symptoms alone without lab testing is unreliable <em>[IIID]</em>. </li>
    <li>Based on a phone description, a nurse triage algorithm may guide screening for GAS <em>[IID]</em>. </li>
    <li>When an appropriately symptomatic patient is &ge;3 years old and has a family member recently diagnosed with laboratory confirmed GAS pharyngitis, one may treat without screening <em>[IID]</em>. </li>
</ul>
<p><strong><span style="text-decoration: underline;">Definitions</span></strong>:</p>
<p><strong>Levels of Evidence</strong></p>
<ol style="list-style-type: upper-alpha;">
    <li>Randomized controlled trials </li>
    <li>Controlled trials, no randomization </li>
    <li>Observational trials </li>
    <li>Opinion of expert panel </li>
</ol>
<p><strong>Strength of Recommendation</strong></p>
<ol style="list-style-type: upper-roman;">
    <li>Generally should be performed </li>
    <li>May be reasonable to perform </li>
    <li>Generally should not be performed </li>
</ol></div>
</div>

</div>
<div class='field field_text'>
<h3>
Clinical Algorithm(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>An algorithm titled "An Approach to the Patient With Pharyngitis" is provided in the original guideline document.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Scope
</h2>
<div class='field field_text'>
<h3>
Disease/Condition(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Pharyngitis</p></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Guideline Category
</h3>
<div class='FieldValue'>
Diagnosis
</div>
<div class='FieldValue'>
Evaluation
</div>
<div class='FieldValue'>
Management
</div>
<div class='FieldValue'>
Treatment
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Clinical Specialty
</h3>
<div class='FieldValue'>
Family Practice
</div>
<div class='FieldValue'>
Internal Medicine
</div>
<div class='FieldValue'>
Pediatrics
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Intended Users
</h3>
<div class='FieldValue'>
Advanced Practice Nurses
</div>
<div class='FieldValue'>
Nurses
</div>
<div class='FieldValue'>
Physician Assistants
</div>
<div class='FieldValue'>
Physicians
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Objective(s)
</h3>
<div class='FieldValue'>
<ul style="list-style-type: disc;">
    <li>To minimize the risk of developing rheumatic fever and suppurative complications </li>
    <li>To utilize symptoms to determine probability of group A streptococcal (GAS) pharyngitis before testing </li>
    <li>To confirm all negative GAS rapid screen results with culture in patients &lt;16 years old </li>
    <li>To reduce indiscriminate use of antibiotics, minimizing adverse effects and bacterial drug resistance </li>
</ul>
</div>

</div>
<div class='field field_text'>
<h3>
Target Population
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Patients 3 years old through adulthood with a sore throat</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Interventions and Practices Considered
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Diagnosis</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Assessment of signs and symptoms </li>
    <li>Rapid group A streptococcal (GAS) screen </li>
    <li>Throat culture </li>
</ol>
<p><strong>Management/Treatment</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Amoxicillin </li>
    <li>Penicillin V </li>
    <li>Benzathine penicillin G </li>
    <li>Cephalexin </li>
    <li>Clindamycin </li>
    <li>Azithromycin </li>
</ol></div>
</div>

</div>
<div class='field field_text'>
<h3>
Major Outcomes Considered
</h3>
<div class='FieldValue'>
<ul style="list-style-type: disc;">
    <li>Diagnostic accuracy </li>
    <li>Rate of prescription of antibiotics </li>
    <li>Symptomatic improvement (i.e., symptom scores) </li>
    <li>Overall duration of symptoms (days) </li>
    <li>Incidence of acute rheumatic fever (ARF)</li>
    <li>Cost-effectiveness </li>
    <li>Adverse effects of antibiotic use</li>
</ul>
</div>

</div>

</div>
<div class='section'>
<h2>Methodology
</h2>
<div class='field field_picklist-many'>
<h3>
Methods Used to Collect/Select the Evidence
</h3>
<div class='FieldValue'>
Hand-searches of Published Literature (Primary Sources)
</div>
<div class='FieldValue'>
Searches of Electronic Databases
</div>

</div>
<div class='field field_text'>
<h3>
Description of Methods Used to Collect/Select the Evidence
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The literature search for this update began with the results of the literature search performed for the 2006 version of this guideline performed in June 2005. A search for literature published since that time was performed. The search on Medline was conducted prospectively for literature published from 6/1/05 to 3/30/11. One set of searches used the major keywords of: GAS pharyngitis (streptococcal infections, streptococcus pyogenes, pharyngitis, pharynx), strep throat; human; English; guidelines, controlled trials, cohort studies. Within these major keywords, specific searches were performed for the following topics: history; physical exam, signs, symptoms throat culture (strep culture); rapid strep screen; observation; antibiotics, other treatment/management, rheumatic fever or group A strep reactive arthritis; and other references found under the major search terms. Specific search terms and strategy are available upon request. Another set of searches used the major keywords of viral pharyngitis/viral sore throat with specific searches performed for: alternative and complimentary therapies (e.g., zinc, vitamin C, echinacea); other treatment.</p>
<p>The search was conducted in components each keyed to a specific causal link in a formal problem structure (available upon request). The search was supplemented with recent clinical trials known to expert members of the panel. Negative trials were specifically sought. The search was a single cycle.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Number of Source Documents
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Not stated</p></div>
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Methods Used to Assess the Quality and Strength of the Evidence
</h3>
<div class='FieldValue'>
Weighting According to a Rating Scheme (Scheme Given)
</div>

</div>
<div class='field field_text'>
<h3>
Rating Scheme for the Strength of the Evidence
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Levels of Evidence </strong></p>
<ol style="list-style-type: upper-alpha;" start="1">
    <li>Randomized controlled trials </li>
    <li>Controlled trials, no randomization </li>
    <li>Observational trials </li>
    <li>Opinion of expert panel </li>
</ol></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Methods Used to Analyze the Evidence
</h3>
<div class='FieldValue'>
Systematic Review
</div>

</div>
<div class='field field_text'>
<h3>
Description of the Methods Used to Analyze the Evidence
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Conclusions were based on prospective randomized controlled trials (RCTs) if available, to the exclusion of other data; if RCTs were not available, observational studies were admitted to consideration. If no such data were available for a given link in the problem formulation, expert opinion was used to estimate effect size.</p></div>
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Methods Used to Formulate the Recommendations
</h3>
<div class='FieldValue'>
Expert Consensus
</div>

</div>
<div class='field field_text'>
<h3>
Description of Methods Used to Formulate the Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Not stated</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rating Scheme for the Strength of the Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Strength of Recommendation</strong></p>
<ol style="list-style-type: upper-roman;">
    <li>Generally should be performed </li>
    <li>May be reasonable to perform </li>
    <li>Generally should not be performed </li>
</ol></div>
</div>

</div>
<div class='field field_text'>
<h3>
Cost Analysis
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Tables 4 and 6 in the original guideline document contain cost information for antibiotic treatment for group A streptococcal pharyngitis and frequent recurrent group A streptococcal pharyngitis.</p></div>
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Method of Guideline Validation
</h3>
<div class='FieldValue'>
Internal Peer Review
</div>

</div>
<div class='field field_text'>
<h3>
Description of Method of Guideline Validation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Drafts of this guideline were reviewed in clinical conferences and by distribution for comment within departments and divisions of the University of Michigan Medical School to which the content is most relevant: Family Medicine, General Internal Medicine, General Pediatrics, Pediatric Medical Surgical Joint Practice Committee, and Mott Executive Committee. The Executive Committee for Clinical Affairs of the University of Michigan Hospitals and Health Centers endorsed the final version.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Recommendations
</h2>
<div class='field field_text'>
<h3>
Type of Evidence Supporting the Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The type of supporting evidence is identified and graded for some of the recommendations (see the "Major Recommendations" field).</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Benefits/Harms of Implementing the Guideline Recommendations
</h2>
<div class='field field_text'>
<h3>
Potential Benefits
</h3>
<div class='FieldValue'>
<ul style="list-style-type: disc;">
    <li>The most important goal in treating group A streptococcal (GAS) infection is to decrease the occurrence of acute rheumatic fever (ARF). </li>
    <li>Appropriate management of individuals with pharyngitis, including those at high risk for complications of GAS (e.g., ARF) </li>
</ul>
</div>

</div>
<div class='field field_text'>
<h3>
Potential Harms
</h3>
<div class='FieldValue'>
<ul style="list-style-type: disc;">
    <li>The value of early diagnosis in the minority of cases when group A streptococcal (GAS) infection is present and identified by antigen testing must be weighed against the higher total laboratory charges for the majority of non-GAS pharyngitis cases which require a confirmatory throat culture in patients less than 16 years old. </li>
    <li>Antibiotic side effects may include rash, nausea, abdominal pain, and/or diarrhea. A single intramuscular injection of benzathine penicillin produces a significant amount of pain at the injection site that may last a number of days, as well as increased risk of anaphylaxis. </li>
    <li>Azithromycin could cause potentially fatal irregular heart rhythm in some patients. At-risk patients include those with a slower-than-normal heartbeat, with potassium or magnesium deficiencies, and those using medications to treat existing heart arrhythmia. </li>
</ul>
</div>

</div>

</div>
<div class='section'>
<h2>Contraindications
</h2>
<div class='field field_text'>
<h3>
Contraindications
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The antibiotic rifampin is relatively contraindicated for pregnant women.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Qualifying Statements
</h2>
<div class='field field_text'>
<h3>
Qualifying Statements
</h3>
<div class='FieldValue'>
<div class="content_para"><p>These guidelines should not be construed as including all proper methods of care or excluding other acceptable methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding any specific clinical procedure or treatment must be made by the physician in light of the circumstances presented by the patient.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Implementation of the Guideline
</h2>
<div class='field field_text'>
<h3>
Description of Implementation Strategy
</h3>
<div class='FieldValue'>
<div class="content_para"><p>An implementation strategy was not provided.</p></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Implementation Tools
</h3>
<div class='FieldValue'>
Clinical Algorithm
</div>
<div class='FieldValue'>
Patient Resources
</div>
<div class='FieldValue'>
Staff Training/Competency Material
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Healthcare Quality Report Categories
</h2>
<div class='field field_picklist-many'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Getting Better
</div>

</div>
<div class='field field_picklist-many'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Effectiveness
</div>
<div class='FieldValue'>
Patient-centeredness
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information and Availability
</h2>
<div class='field field_citation'>
<h3>
Bibliographic Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>University of Michigan Health System. Pharyngitis. Ann Arbor (MI): University of Michigan Health System; 2013 May. 10 p.  [10 references]</td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date Released
</h3>
<div class='FieldValue'>
1996 Nov (revised 2013 May)
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Guideline Developer(s)
</h3>
<div class='FieldValue'>
University of Michigan Health System - Academic Institution
</div>

</div>
<div class='field field_text'>
<h3>
Source(s) of Funding
</h3>
<div class='FieldValue'>
<div class="content_para"><p>University of Michigan Health System</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Committee
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Pharyngitis Guideline Team</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of Group That Authored the Guideline
</h3>
<div class='FieldValue'>
<div class="content_para"><p><em>Team Leader</em>: Terrance P Murphy, MD, Pediatrics</p>
<p><em>Team Members</em>: R Van Harrison, PhD, Medical Education; Annissa J Hammoud, MD, Internal Medicine-Pediatrics; Gary Yen, MD, Family Medicine</p>
<p><em>Consultants</em>: Kristin C Klein, PharmD, College of Pharmacy</p>
<p><em>Guidelines Oversight Team</em>: Grant Greenberg, MD, MA, MHSA; R Van Harrison, PhD</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The University of Michigan Health System endorses the Guidelines of the Association of American Medical Colleges and the Standards of the Accreditation Council for Continuing Medical Education that the individuals who present educational activities disclose significant relationships with commercial companies whose products or services are discussed. Disclosure of a relationship is not intended to suggest bias in the information presented, but is made to provide readers with information that might be of potential importance to their evaluation of the information.</p>
<p>Neither the members of the Pharyngitis guideline team nor the consultant have a relationship with commercial companies whose products are discussed in this guideline.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: University of Michigan Health System. Pharyngitis. Ann Arbor (MI): University of Michigan Health System; 2006 Oct. 10 p. [9 references]</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Electronic copies: Available from the <a href="http://www.med.umich.edu/1info/fhp/practiceguides/pharyngitis.html" title="University of Michigan Health System Web site">University of Michigan Health System Web site</a>.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Availability of Companion Documents
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Continuing Medical Education (CME) information is available from the <a href="http://ocpd.med.umich.edu/cme/self-study/Pharyngitis" title="University of Michigan Health System Web site">University of Michigan Health System Web site</a>.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Patient Resources
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The following is available:</p>
<ul style="list-style-type: disc;">
    <li>Sore throat (pharyngitis). University of Michigan Health System; 2012 Jul. 2 p. Electronic copies: Available in Portable Document Format (PDF) from the <a href="http://www.med.umich.edu/1info/fhp/practiceguides/pharyngitis/Pharyngitis.pdf" title="University of Michigan Health System Web site">University of Michigan Health System Web site</a>. </li>
</ul>
<p class="Disclaimer">Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
NGC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This summary was completed by ECRI on May 20, 1999. The information was verified by the guideline developer on June 17, 1999. This summary was updated by ECRI on December 14, 2001. The updated information was verified by the guideline developer as of February 8, 2002. This summary was updated by ECRI Institute on April 23, 2007. The updated information was verified by the guideline developer on April 25, 2007. This NGC summary was updated by ECRI Institute on October 21, 2013.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NGC summary is based on the original guideline, which is copyrighted by the University of Michigan Health System (UMHS).</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NGC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p>
</div>

</div>

</div>
</body></html>